Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
KYNB

Market Cap: $32.26M

KI

Kyntra Bio, Inc.

KYNB

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin18.15%

EBITDA Margin-20.36%

EBIT Margin-20.41%

Pre-tax Margin-6.70%

Net Profit Margin39.68%

Earnings Yield5.68%

Valuation Multiples

Price / Book-1.07

Price / Sales6.99

Price / Earnings0.14

PEG0.00

Forward PEG0.00

EV / Sales-3.98

EV / EBITDA0.20

EV / Operating Cash Flow0.48

EV / Free Cash Flow0.48

Price / Free Cash Flow-0.85

Price / Operating Cash Flow-0.85

Cash Flow & Capital

Free Cash Flow / Share-$9.4

Operating Cash Flow / Share-$9.4

Free Cash Flow Yield-1.18%

Capex / Revenue0.19%

Capex / Operating Cash Flow-0.02%

Capex / Depreciation0.04

Stock Compensation / Revenue86.33%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.69

Quick Ratio2.59

Cash Ratio1.41

Debt / Assets0.00

Debt / Capital0.00

Debt / Equity0.00

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA0.54

Solvency Ratio1.68

Financial Leverage-3.35

Efficiency & Working Capital

Asset Turnover0.05

Fixed Asset Turnover0.00

Inventory Turnover1.12

Receivables Turnover13.31

Payables Turnover0.50

Days Sales Outstanding27.43

Days Inventory Outstanding326.85

Days Payables Outstanding725.36

Operating Cycle354.28

Cash Conversion Cycle-371.08

Working Capital Turnover0.07

Returns & Quality

Return on Equity-6.06%

Return on Assets1.81%

Return on Invested Capital-78.16%

ROCE-78.16%

Return on Tangible Assets1.81%

Operating Return on Assets-48.25%

Income Quality-0.21

Tax Burden-5.93

Interest Burden0.33

Balance Sheet & Intrinsic Metrics

Enterprise Value$-18.38M

Invested Capital$60.79M

Working Capital$60.79M

Tangible Asset Value$-8.14M

Net Current Asset Value$-12.4M

Graham Net-Net-$3.94

Book Value / Share-$2.01

Tangible Book Value / Share-$2.01

Cash / Share$22.56

Financial Health Scores

Piotroski Score5

Altman Z-Score-25.80

Revenue$4.62M

EBIT$-94.22M

Market Cap$32.47M

Working Capital$60.79M

Retained Earnings$-1.71B

Total Assets$101.08M

Total Liabilities$109.22M